Cite
Poster: AML-131 ERG: From a Fortuitous Discovery to Potential Treatment for AML
MLA
Eitan Kugler, et al. “Poster: AML-131 ERG: From a Fortuitous Discovery to Potential Treatment for AML.” Clinical Lymphoma Myeloma and Leukemia, vol. 22, Oct. 2022, p. S129. EBSCOhost, https://doi.org/10.1016/s2152-2650(22)00769-8.
APA
Eitan Kugler, Shreyas Madiwale, Darren Yong, Yehudit Birger, Julie AI Thoms, David B Sykes, Muhammad Yassin, Nasma Aqaqe, Avigail Rein, Hila Fishman, Ifat Geron, Chun-Wei Chen, Brian Raught, Qiao Liu, Michael Milyavsky, John Pimanda, Gilbert G Privé, & Shai Izraeli. (2022). Poster: AML-131 ERG: From a Fortuitous Discovery to Potential Treatment for AML. Clinical Lymphoma Myeloma and Leukemia, 22, S129. https://doi.org/10.1016/s2152-2650(22)00769-8
Chicago
Eitan Kugler, Shreyas Madiwale, Darren Yong, Yehudit Birger, Julie AI Thoms, David B Sykes, Muhammad Yassin, et al. 2022. “Poster: AML-131 ERG: From a Fortuitous Discovery to Potential Treatment for AML.” Clinical Lymphoma Myeloma and Leukemia 22 (October): S129. doi:10.1016/s2152-2650(22)00769-8.